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Calcitonin Gene-Related Peptide Partially Reverses
Decreased Production of Chemokines KC and MIP-2
Following Murine Sepsis1
Xian Wang,1,2 Samuel J. Ebong,1 Douglas R. Call,1 David E. Newcomb,1 Gerald R.
Bolgos,1 and Daniel G. Remick1,3
Abstract—The secretion of calcitonin gene-related peptide (CGRP) and the chemokines KC and
MIP-2 are increased in the animal models of endotoxemic and septic shock. We tested whether
CGRP could modulate KC and MIP-2 secretion from different sources of macrophages after murine
sepsis induced by cecal ligation and puncture (CLP). Macrophages were obtained from the peri-
toneal exudate and lung of female BALB/ c mice 16 h after CLP and plated in culture with CGRP
and/ or LPS for 12 h. The results showed that peritoneal macrophage production of the chemo-
kines (KC, MIP-2) and cytokines (TNF-a, IL-6) was markedly decreased in CLP mice. Alveo-
lar macrophages did not display decreased cytokine/ chemokines production after CLP. CGRP (0.1
nM–10 nM) partially reversed this decreased production of LPS-induced KC and MIP-2 from peri-
toneal macrophages. These results suggest that CGRP might be intimately involved in recruitment
of neutrophils by promoting local production of the chemokines KC and MIP-2 in murine sepsis.
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INTRODUCTION
Substantial data has been published demonstrating that
neuroendocrine hormones and neuropeptides can regu-
late the immune response. The sensory nerve endings are
in close contact with several components of the immuno-
logical system, thus immunological functions may be
affected by the neurotransmitter CGRP from the sensory
nerve endings (1). In addition, we have shown recently
that CGRP can be synthesized and released in T lym-
phocytes, especially mitogen activated T lymphocytes
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in the rat (2). By using a CGRP1 receptor antagonist,
hCGRP8−37, we have shown that although lymphocytes
produce much less CGRP than dorsal root ganglia, suf-
ficient amounts appear to be secreted to stimulate bio-
logical processes, such as suppression of proliferation
and IL-2 production by T lymphocytes. Both cellular
sources of CGRP may act on the same receptor of target
cells, although the secretion from lymphocytes and neu-
rons require different stimulants. It appears that CGRP
performs many functions in an autocrine or paracrine
fashion within the immune system. Specific receptors for
CGRP are present on various cells of the immune system
(3, 4) and CGRP has been shown previously to modulate
a number of immune functions (5).
It has been reported that CGRP can inhibit IFN-g-
induced peroxide production, suppress antigen presenta-
tion by macrophages and increase intracellular cAMP (4,
6). The data have shown that CGRP can inhibit LPS-
induced TNF and IL-12 production in cultured mouse
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peritoneal macrophages through the activation of cAMP
pathway in murine macrophages (7, 8).
Also, it has been reported that CGRP promotes
the rapid onset and prolonged activation of leuko-
cyte adhesion to vaso-endothelium (9). In synergy with
inflammatory mediators such as bacterial peptide, FMLP
or complement fragment C5a, CGRP was reported to
induce edema formation and neutrophil accumulation
(10), however, the mechanism of CGRP’s effects is
not known, although modulation of chemokines may
be involved. The chemotactic cytokines (chemokines)
are potent and specific chemoattractants for inflam-
matory cells (11). The C-X-C chemokines primarily
serve to recruit neutrophils to local sites of inflamma-
tion (12). The exact murine homolog of human IL-8,
a major C-X-C chemokine in humans, has not been
identified, but the two most probable candidates are
KC (13) and macrophage-inflammatory protein-2 (MIP-
2) (14). Therefore, we hypothesized that CGRP might
stimulate chemotaxis via modulating production of the
C-X-C chemokines KC and MIP-2.
Previous publications have demonstrated that the
systemic levels of CGRP, KC, and MIP-2 are increased
in endotoxemia or sepsis in animals and humans
(15–18). Therefore, we hypothesized that CGRP may
modulate chemokine secretion from the macrophages
in the murine model of sepsis induced by CLP. The
response of two sources of macrophages to CGRP in
the mouse CLP model was investigated in the present
study and the date indicated that the production of C-
X-C chemokines, KC and MIP-2, and cytokines, TNF-
a and IL-6, in response to LPS by peritoneal, but not
alveolar macrophages was significantly reduced follow-
ing CLP. Due to this suppression, CGRP reversed the
decreased production LPS induced chemokines, KC and
MIP-2, from peritoneal macrophages.
MATERIALS AND METHODS
Animals
BALB/ c mice, 18–22 g, were obtained from Har-
lan Sprague Dawley, Inc. (Indianapolis, IN) and main-
tained under standard laboratory condition. In addition
to a resting period at the institutional vivarium, mice
were acclimated to the laboratory environment for at
least 24 h before surgery. After CLP, mice were housed
in a temperature-controlled room with food and water
ad libitum, and were kept under a 12-h light/ 12-h dark
diurnal cycle. The experiments were performed in accor-
dance with the National Institute of Health guidelines
and approval was obtained from the University of Michi-
gan Animal Use Committee.
CLP
CLP was performed as previously described (19).
Female BALB/ c mice were anesthetized with ketamine/
rompun, intraperitoneally, 87/ 13 mg/ kg of body weight
(Ketamine, Fort Dodge Laboratories, Inc., Fort Dodge,
IA; Rompun, Bayer Corporation, Shawnee Mission, KS).
The peritoneum was opened sterilely and the cecum tied
with 4.0 silk surgical thread 1 cm from the distal end, care
was taken not to obstruct the illeocecal valve. Two punc-
tures were made by passing a 21 gauge needle through
the cecum distal to the point of ligation. The needle was
removed and a small amount of the stool was extruded
from the punctures to ensure patency. The abdominal cav-
ity was closed with running sutures using sterile 4.0 silk
sutures, and the skin closed with 9 mm stainless steel
removable would clips. After the surgery, the mice were
injected subcutaneously with 1 ml of prewarmed normal
saline before being placed into their cage. Two h and
then 12 h after surgery, each mouse received subcutaneous
injections of imipenem, 0.5 mg/ mouse (Primaxin, Merck
and Co., Inc., West Point, PA), reconstituted in 1 ml of
5% dextrose for fluid resuscitation. We have previously
reported that imipenem treatment reduces mortality and
morbidity in the CLP model and was superior to the use
of triple antibiotics (17). Mice were sacrificed at 16 h and
samples collected for later analyses.
Peripheral Blood Analyses
At the time of sacrifice, mice were lightly anes-
thetized with ketamine/ xylazine and 20 ml of EDTA anti-
coagulated blood was collected from the tail. A Hemavet
Mascot Multispecies Hematology System Counter 1500R
(CDC Technologies Inc., Oxford, CT) was then used
to perform a complete blood count, this automated sys-
tem operates through light scattering technology. Forward
angle light scatter detects cells based on size (similar to
flow cytometry) while the side angle (or 908C) scatter
determines cell-type-based cellular granularity.
Preparation of Macrophage Populations
After blood collection, mice were euthanized by
cervical dislocation, then macrophages were obtained
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from the lavage of peritoneal and lung exudate as pre-
viously described by our laboratory (18). The total cell
count was carried out using a Coulter counter (model
ZF, Coulter Electronics Inc., Hialeah, FL). Red blood
cells were lysed using Zap-Oglobin II (Coulter) to ensure
that only WBCs would be counted. The cells from two
sources were then prepared for differential counts using
a cytospin (final cell concentration of 1 × 105 in 200
ml of cytospin fluid), centrifuged at 700× g for 5 min;
cytospin fluid consisted of RPMI 1640 and 1% FCS.
The cytospins were then stained with Diff-Quick (Bax-
ter, Detroit, MI) and WBC types were quantified under
oil immersion lens after tallying 300 cells. The total for
each cell type was calculated by dividing each cell type
by 300 and multiplying by the total WBC obtained from
the Coulter counter.
The cells were plated on culture dishes at a density
of 5 × 104 cells per well for alveolar macrophages, and
2 × 105 cells per well for peritoneal macrophages in 1
ml RPMI-1640 containing 10% FCS and antibiotics (1%
pen/ strep) at 378C in a humidified atmosphere at 5%
CO2 and 95% room air. Macrophages were allowed to
adhere for 2 h and washed with Hank’s balance salt solu-
tion 3× . This method provided adherent cells that exhib-
ited typical macrophage morphology. The production of
cytokines in the peritoneum was normalized to the total
number of macrophages that were placed in culture. This
was done by determining the number of macrophages
in the lavage fluid and expressing the cytokine measure-
ments as ng or pg/ million plated macrophages. This was
done since a million total peritoneal cells from the CLP
group would contain substantially fewer macrophages
than the sham group due to the recruitment of neu-
trophils. The percentage of macrophages in 300 cells of
peritoneal exudate was decreased from 90% in the sham
to 48% in the CLP due to the influx of neutrophils. No
such change was observed in the alveolar cells.
Stimulation and Measurement of Cytokine
Production
The macrophages were incubated with rCGRP (1
pM–10 nM, rat sequence, CGRP type 1, CGRP-a)
(Peninsular Laboratory, CA) or/ and 0.01 mg/ ml lipo-
polysaccharide (LPS, E. coli O111:B4) (Sigma, St.
Louis, MO) for 12 h in culture, then the cell super-
natants were collected and frozen. All samples for
cytokine production analysis were measured simultane-
ously to reduce errors due to assay variation. TNF-a lev-
els were quantified by cytolytic activity directed against
the WEHI 164 subclone 13 fibrosarcoma cell line as
previously described (20). Briefly, samples were serially
diluted across a flat bottom 96-well plate in 100 ml RPMI
1640 culture media supplemented with 1% FCS and 1
mM L-glutamine. WEHI cells in RPMI 1640 (100 ml)
containing 10% FCS, 1 mM L-glutamine, 30 mg gen-
tamicin and 0.5 mg/ ml actinomycin D were added on
top of the samples. The plates were allowed to incubate
overnight at 378C in a humidified chamber with 5% CO2
followed by addition of MTT-Tetrazolium (Sigma, St.
Louis, MO). Plates were returned to the incubator for
an additional 4 h followed by the addition of acidified
isopropanol and kept overnight at room temperature in a
darkened chamber. Readings were performed at 550 nm
with background subtraction at 630 nm. TNF-a levels
were then extrapolated from a standard curve of human
recombinant TNF-a (Cetus Corp., Emeryville, CA) that
was used in the same assay, which was sensitive to 1–2
pg/ ml of TNF.
IL-6 levels were determined by a bioassay using the
B-9 cell, that proliferate in the presence of IL-6 (21).
Serial dilutions of the samples were made in 96-well
plates and B-9 cells suspended in Isocove’s media con-
taining 2 mM glutamine, 25 mM HEPES, 1% pen/ strep,
b-mercaptoethanol (50 mM), and 10% FCS. The cells
were incubated for 3 days at 378C in humidified cham-
ber. MTT-tetrazolium was then added and incubated for
6 h followed by the addition of acidified isopropanol
overnight. Samples were then read and the results cal-
culated based on a standard curve of the human recom-
binant IL-6 (PepcoTech, Rocky Hill, NJ) run in the same
assay, which reliably detected samples as low as 1–2
pg/ ml.
KC and MIP-2 levels were quantitated by ELISA
as described in our previously published methods (22).
Briefly, rabbit polyclonal antibodies were raised against
murine recombinant KC or MIP-2-a, purified, and used
as capture antibodies. The plates were coated with the
antibody overnight, blocked for 1 h on the nutator at
room temperature before the addition of samples and
standards, which were also placed on the nutator for 1 h.
Biotinylated antibody was then added for 1 h followed
by streptavidin-HRP (Jackson ImmunoRes. Labs, Inc.,
PA). Peroxidase substrate was then added and plates
were allowed to develop for 20 min in the dark before
the reaction was stopped with 3 M H2SO4. Plates were
read at dual wavelengths of 490 nm and 630 nm. Sample
concentrations were determined by comparison to a stan-
dard curve, which was prepared using the recombinant
KC, which did not cross-react with MIP-2, and MIP-2-a.
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The lower limits of detection for KC and MIP-2-a were
100 pg/ ml and 25 pg/ ml, respectively.
Statistical Analysis
The results were expressed as the mean ±SEM. The
number of experimental animals used for each group
was presented as ‘n’ value in the figure legends. The
data were analyzed using one-way ANOVA and fur-
ther analyzed using the Student-Newman-Keuls’ test
for multiple comparisons between treatment groups and
using unpaired student t-test for comparison between two
groups. A p- value of <0.05 was considered significant
for differences between treatment group means.
RESULTS
Alterations in Inflammatory Cells
In agreement with our previous report (18), the
peripheral blood WBC was reduced due to a decrease in
neutrophils, lymphocytes, and monocytes 16 h after CLP
(Table 1). However, as we reported before (23), there
was a significant elevation in the total number of cells
obtained from the peritoneum 16 h after CLP while there
was no increase in the recovery of cells from the lung
(data not shown). The increase in peritoneal cell number
was due to a substantial neutrophil influx.
Cytokine and Chemokine Changes in Plasma and
Peritoneum
Similar to our previous report (23), there were sig-
nificant increases in the murine cytokine IL-6 and the
C-X-C chemokines, KC and MIP-2, at the site of inflam-
mation, the peritoneum 16 h after CLP with a 21 gauge
needle (Table 2). In this model, plasma IL-6, KC, and
MIP-2 levels were also increased after CLP (Table 2).
Cytokine/ Chemokine Production Following CLP
We evaluated the ability of cells from the two dif-
ferent cellular compartments to respond to an in vitro
challenge with LPS. The results are normalized to the
total number of macrophages present in the cell suspen-
sion for the peritoneal cells, as described in the methods
section. Therefore, the results are all expressed as pg of
cytokine/ chemokine per million macrophages.
Table 1. Peripheral Blood Leukocytes 16 Hours after CLP or Sham Surgery
Group n WBC PMNs Lymphs Monocytes
Sham 14 23.8 ± 1.1* 8.8 ± 0.4* 13.3 ± 0.7* 0.98 ± 0.05*
CLP 14 8.3 ± 1.1 2.3 ± 0.2 5.3 ± 0.7 0.4 ± 0.03
Values are cells × 10−6/ ml. Each value is the mean ± SEM.
*n c p < 0.001 sham compared to CLP.
Table 2. Plasma and Peritoneal Levels of Cytokines and Chemokines 16 Hours After CLP or
Sham Surgery
Group N IL-6 KC MIP-2
Plasma
Sham 12 0.17 ± 0.05** 14.9 ± 1.8* 1.7 ± 0.4*
CLP 12 81.1 ± 0.3 1544 ± 603 22.1 ± 3.8
Peritoneum
Sham 12 0.20 ± 0.06** 0.09 ± 0.02* 0.15 ± 0.03**
CLP 12 407 ± 106 4.3 ± 1.4 7.6 ± 1.9
*Values are ng/ ml and each value is the mean ± SEM.
*
c p < 0.02.
**n c p < 0.001 sham compared to CLP.
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Figure 1 shows the production of the cytokines,
TNF-a, IL-6 and C-X-C chemokines, KC and MIP-
2, from the peritoneal and alveolar macrophages in
response to an LPS stimulus. Cells harvested from the
peritoneum of mice who had undergone CLP 16 h pre-
viously had a significantly reduced capacity to produce
TNF-a, IL-6, KC, and MIP-2 in response to the LPS
challenge. In contrast, there was no reduction in the
response of the alveolar macrophages to produce these
cytokines and chemokines (Fig. 1A, B, C, and D). These
data demonstrate for the first time that C-X-C chemo-
kines, KC and MIP-2, production in response to LPS
by peritoneal, but not alveolar macrophages was signif-
icantly reduced after a septic challenge due to CLP.
Effect of CGRP on Chemokine Production
We specifically sought to determine if modulation
of chemokine production might occur by attempting to
augment chemokine production by CGRP since CGRP
has been reported to stimulate chemotaxis (9, 10). Peri-
toneal macrophages harvested 16 h after CLP, at a time
of decreased chemokine production were stimulated with
LPS (0.01 mg/ ml). CGRP augmented chemokine produc-
tion by the peritoneal macrophages in a dose-dependent
manner, both KC (Fig. 2) and MIP-2 (Fig. 3) production
was increased. This augmentation of chemokine produc-
tion was observed at very low concentrations of CGRP
(0.01– 10 nM), this effect was not observed in peritoneal
Fig. 1. Decreased TNF-a, IL-6, KC, and MIP-2 production after in vitro LPS stimulation of cells obtained from CLP mice. Peritoneal or
alveolar macrophages were collected from the peritoneal exudates and lungs 16 h after sham surgery or CLP. Adherent macrophages were
obtained and then stimulated with LPS (0.01 mg/ ml) for 12 h. There was a significant decrease in TNF-a (A), IL-6 (B), KC (C), and MIP-2
(D) production from murine peritoneal macrophages, but not alveolar macrophages in the mice after CLP compared to the sham mice. The data
are expressed as mean ±SEM for 6 mice. * c P < 0.05 CLP compared to sham.
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Fig. 2 Comparison of the effect of CGRP on LPS-stimulated in vitro
levels of KC by peritoneal macrophages from sham surgery or CLP
mice. Adherent macrophages were obtained from peritoneal cells after
16 h of either sham surgery or CLP. These cells were stimulated with
LPS (0.01 mg/ ml) and increasing concentrations of CGRP (1 pM–10
nM). CGRP augmented LPS induced KC production by macrophages
obtained from mice subjected to CLP but not in the sham mice. The
data are expressed as the percent of the LPS alone and each point is
the mean ±SEM for 6 mice. * P < 0.05 vs LPS alone, # P < 0.05 CLP
compared to sham surgery.
cells obtained from sham surgery mice, as can be observed
in Figs. 2 and 3. Additionally, CGRP did not increase
chemokine production from alveolar macrophages taken
from either sham or CLP mice (data not shown).
Fig. 3 Comparison of the effect of CGRP on LPS-stimulated in vitro
levels of MIP-2 by peritoneal macrophages from sham surgery or CLP
mice. Adherent macrophages were obtained from peritoneal cells after
16 h of either sham surgery or CLP. All cells were stimulated with LPS
(0.01 mg/ ml) and increasing concentrations of CGRP (1 pM–10 nM).
CGRP augmented LPS induced MIP-2 production by macrophages
obtained from mice subjected to CLP but not in the sham mice. The
data are expressed as the percent of the LPS alone and each point is
the mean ±SEM for mice. * P < 0.05 vs LPS alone, # P < 0.05 CLP
compared to sham surgery.
When the two sources of macrophages were stimu-
lated with CGRP alone, the levels of chemokine examined
in the culture medium were very low. CGRP had no direct
effect on KC or MIP-2 production from the macrophages
taken from either the sham or the CLP mice.
DISCUSSION
This study shows, for the first time, that C-X-C
chemokine (KC and MIP-2) production in response to
LPS by peritoneal, but not alveolar macrophages, was
significantly reduced after a septic challenge due to CLP.
This reduction of LPS induced chemokine production
from peritoneal macrophages following CLP was par-
tially reversed by the polypeptide CGRP.
It has been reported that tissue-specific macrophages
have a differential response to hemorrhage, trauma,
endotoxin, or sepsis (24–26). Ayala and Chaudry (27–29)
have reported that region-specific macrophages functions
are altered after hemorrhage and resuscitation. Cecal lig-
ation and puncture-induced sepsis differentially affects
splenic, peritoneal, and pulmonary macrophages (24,
30). The differences in the local release of inflamma-
tory mediators by adjacent cell populations represents
one potential mechanism (25). Another possibility is
that various macrophage subpopulations constitutively
express different intracellular kinases involved in the
regulation of monokine production (31). The reduced
level of cytokine and chemokine release in response to
LPS by peritoneal macrophages as compared to alveo-
lar macrophages is most likely due to the prior activa-
tion in vitro by stimulants, i.e., endotoxin or cytokines. In
CLP model, the peritoneal macrophages are more prox-
imal to the intraabdominal septic insult, while the alve-
olar macrophages are more distal.
During sepsis, there are marked elevations in the
number of cells and neutrophils obtained from the peri-
toneum following CLP (23). Since neutrophils play a
key role in the elimination of invading microorganism,
an important mechanism of host defense is neutrophil
influx into the peritoneum which represents the local site
of inflammation in this model. An improvement in the
recruitment and function of neutrophils could lead to a
reduced mortality due to sepsis. There are reports of sig-
nificant IL-8 elevation in multiple organ failure patients
(32). Previous reports have shown that an increase in
two murine IL-8 analogs, KC, and MIP-2 (17, 18) occurs
in murine sepsis. We have showed in the present study
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there were significant increases both in the numbers of
neutrophils recruited into the peritoneum and the lev-
els of murine C-X-C chemokines, KC and MIP-2, in
peritoneum and plasma after CLP with a 21 gauge nee-
dle. The murine C-X-C chemokines, KC and MIP-2, are
known as neutrophil chemotactic mediators (33).
In certain pathological conditions, an abnormally
high local level of CGRP may be associated with altered
immune function. For example, plasma levels of CGRP
were found to be elevated more then seven-fold above
the basal level in patients in the late stage of septic
shock. Additionally, it was elevated by 30 min in a rat
endotoxin shock model, and continued to increase up to
3 h (15, 16). The CGRP release during septic shock may
reach sufficiently high concentrations locally to modu-
late some immunocyte activities via paracrine mecha-
nisms, including the elevation of LPS-induced KC and
MIP-2 production as reported in the present study. It
has been postulated that cytokines and chemokines con-
tribute significantly to the pathophysiology of sepsis and
septic shock (33). An early release of KC and MIP-
2 into the local tissue milieu may initiate and achieve
many of the beneficial responses aimed at improving
antimicrobial function and reducing tissue damage. We
anticipate that CGRP may exert neuroimmunomodula-
tory effects by augmenting KC and MIP-2 release from
mono/ macrophages at the early stage of sepsis or other
inflammatory responses. This would exert a beneficial
effect by augmenting recruitment of neutrophils to the
local site of inflammation to clear the invading bacteria.
However, the release of CGRP was thought to be associ-
ated with the hypotension, tachycarida, and immune sup-
pression in late stage of endotoxin shock (34, 35). Fur-
ther studies are needed to elucidate the role of CGRP in
the sepsis in vivo.
In conclusion, the polypeptide CGRP can modu-
late a number of immune functions. Hypo-responsiveness
to subsequent LPS challenge was selectively found by
diminished peritoneal macrophage production of not only
cytokines, TNF-a and IL-6, but also the chemokines, KC
and MIP-2, in the murine CLP model. CGRP was able to
partially reverse the decreased production of KC and MIP-
2. These results suggest the peptide CGRP might be inti-
mately involved in recruitment of neutrophils by promot-
ing local production of the chemokines, KC and MIP-2, in
murine sepsis and might serve to provide ongoing recruit-
ment of neutrophils to the local site of inflammation.
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